Nephrotoxic drugs: Difference between revisions
No edit summary |
|||
Line 77: | Line 77: | ||
==Miscellaneous Drugs== | ==Miscellaneous Drugs== | ||
* Chronic stimulant [[Laxative]] use | * Chronic stimulant [[Laxative]] use | ||
:* Resulting chronic volume depletion and [[ | :* Resulting chronic volume depletion and [[hypokalemia]] causes [[nephropathy]] | ||
* [[Radiocontrast agents]] | * [[Radiocontrast agents]] | ||
* [[ACE Inhibitor]]s | * [[ACE Inhibitor]]s | ||
Line 108: | Line 108: | ||
*[[Rifampin]] | *[[Rifampin]] | ||
*[[Sulfonamide]]s | *[[Sulfonamide]]s | ||
:*[[Vasculitis]] reaction | :*[[Vasculitis]] reaction | ||
==Drugs of abuse== | ==Drugs of abuse== |
Revision as of 22:13, 9 August 2012
WikiDoc Resources for Nephrotoxic drugs |
Articles |
---|
Most recent articles on Nephrotoxic drugs Most cited articles on Nephrotoxic drugs |
Media |
Powerpoint slides on Nephrotoxic drugs |
Evidence Based Medicine |
Cochrane Collaboration on Nephrotoxic drugs |
Clinical Trials |
Ongoing Trials on Nephrotoxic drugs at Clinical Trials.gov Trial results on Nephrotoxic drugs Clinical Trials on Nephrotoxic drugs at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Nephrotoxic drugs NICE Guidance on Nephrotoxic drugs
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Nephrotoxic drugs Discussion groups on Nephrotoxic drugs Patient Handouts on Nephrotoxic drugs Directions to Hospitals Treating Nephrotoxic drugs Risk calculators and risk factors for Nephrotoxic drugs
|
Healthcare Provider Resources |
Causes & Risk Factors for Nephrotoxic drugs |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Aarti Narayan, M.B.B.S [3]
Overview
Nephrotoxic drugs are pharmacotherapies that can lead to a decline in renal function. The drug may need to be discontinued, or the dosing reduced when this happens.
Antibiotics
- Acyclovir (only nephrotoxic in intravenous form)
- Aminoglycosides (10-15% Incidence of Acute Tubular Necrosis)
- Occurs in 10-20% patients on 7 day course
- Results in non-oligurics; increased Creatinine
- A single dose early in septic course is usually safe
- Amphotericin B (Incidence 80-90%)
- Ciprofloxacin
- Chloroquine
- Erythromycin
- Foscarnet
- Gentamycin
- Hydroxychloroquine
- Indinavir
- Isoniazide
- Levofloxacin
- Methicillin
- Pentamidine
- Quinine
- Rifampin
- Sulfonamides
- Tetracycline
- Tenofovir
- Trimethadione
- Vancomycin
Chemotherapy and Immunosuppressants
Heavy Metals and Poisons
- Polydipsia and Nephrogenic Diabetes Insipidus
- Acute Renal Failure
- Dialysis indications: Creatinine >2.5 or Seizures, ALOC, Rhabdomyolysis
- Chronic kidney disease with fibrosis
- Mercury Poisoning
- Nitrosourea compounds
AntiHyperlipidemics
- Fenofibrate (Tricor)
- Increases serum creatinine without significant decrease in GFR
- Serum creatinine rise is reversible on stopping Fenofibrate
- Associated with Acute Renal Failure due to Rhabdomyolysis
Chemotherapy
- Causes Fanconi's Syndrome
Proton channel blockers
Miscellaneous Drugs
- Chronic stimulant Laxative use
- Resulting chronic volume depletion and hypokalemia causes nephropathy
- Expect an increase of serum creatinine in chronic kidney disease
- Low dose Aspirin reduces Renal function in elderly
- Decreased Creatinine Clearance after 2 weeks of use
- Changes persisted for at least 3 weeks off Aspirin
- Low dose Aspirin reduces Renal function in elderly
- Infliximab
- Interferons
- Mesalamine (Asacol, Pentasa)
- Mesalamine is an NSAID analog and has systemic absorption from the bowel
- Nephrotic Syndrome type reaction
- Vasculitis reaction